# Axcelead > Drug Discovery Partners --- ## Pages - [Axcelead Booster](https://axcelead-us.com/integrated-drug-discovery/axcelead-booster/): Integrated Drug Discovery Axcelead Booster Accelerating Drug Candidate Generation With Our Pharma-originated Discovery Platform What is Axcelead Booster (A-Booster)? —... - [Home](https://axcelead-us.com/): The Future of Drug Discovery is Here. Axcelead accelerates the discovery and development of high-value therapeutic candidates for the preclinical... - [Home](): The Future of Drug Discovery is Here. Axcelead accelerates the discovery and development of high-value therapeutic candidates for the preclinical... - [Genetically Modified Animal](https://axcelead-us.com/genetically-modified-animal/): Axcelead High Throughput Screening services are designed to help you create truly novel, original drugs rapidly with our integrated platform. Whether you're in the pharmaceutical, biotechnology, or academic sector, our comprehensive screening solutions can help you achieve your scientific goals more efficiently. - [Bioinformatics](https://axcelead-us.com/bioinformatics/): Axcelead High Throughput Screening services are designed to help you create truly novel, original drugs rapidly with our integrated platform. Whether you're in the pharmaceutical, biotechnology, or academic sector, our comprehensive screening solutions can help you achieve your scientific goals more efficiently. - [Topics](https://axcelead-us.com/topics/): News Topics 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 - [News Releases](https://axcelead-us.com/news-releases/): News News Releases 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 - [Omics](https://axcelead-us.com/omics/): Axcelead High Throughput Screening services are designed to help you create truly novel, original drugs rapidly with our integrated platform. Whether you're in the pharmaceutical, biotechnology, or academic sector, our comprehensive screening solutions can help you achieve your scientific goals more efficiently. - [Chemistry](https://axcelead-us.com/chemistry/): Axcelead Chemistry services are designed to help you create the medicines of the future. Whether you're in the pharmaceutical, biotechnology, or academic sector, our comprehensive chemistry solutions can help you achieve your scientific goals more efficiently. - [Small Molecules](https://axcelead-us.com/small-molecules/): Axcelead is your partner in Targeted Protein Degradation Drug Discovery! Axcelead has comprehensive capabilities in Targeted Protein Degradation Drug Discovery drug discovery at the preclinical stages and a proven track record. Whether you are in the pharmaceutical, biotechnology, or academic sector, our comprehensive solutions can help you achieve your scientific goals more efficiently. - [Targeted Protein Degraders](https://axcelead-us.com/targeted-protein-degraders/): Axcelead is your partner in Targeted Protein Degradation Drug Discovery! Axcelead has comprehensive capabilities in Targeted Protein Degradation Drug Discovery drug discovery at the preclinical stages and a proven track record. Whether you are in the pharmaceutical, biotechnology, or academic sector, our comprehensive solutions can help you achieve your scientific goals more efficiently. - [RNA-Targeted Small Molecules](https://axcelead-us.com/rna-targeted-small-molecules/): Axcelead is your partner in RNA-Targeted Drug Discovery! Axcelead has comprehensive capabilities in integrated RNA-targeted small molecule drug discovery at the preclinical stages. Whether you are in the pharmaceutical, biotechnology, or academic sector, our comprehensive solutions can help you achieve your scientific goals more efficiently. - [Peptide](https://axcelead-us.com/peptide/): Axcelead is your partner in Peptide Drug Discovery! Axcelead peptide drug discovery services are designed to accelerate your peptide drug project with our comprehensive platform. Whether you are in the pharmaceutical, biotechnology, or academic sector, our comprehensive solutions can help you achieve your scientific goals more efficiently. - [High Throughput Screening](https://axcelead-us.com/high-throughput-screening/): Axcelead High Throughput Screening services are designed to help you create truly novel, original drugs rapidly with our integrated platform. Whether you're in the pharmaceutical, biotechnology, or academic sector, our comprehensive screening solutions can help you achieve your scientific goals more efficiently. - [Oligonucleotide](https://axcelead-us.com/oligonucleotide/): Axcelead is your partner in Oligonucleotide Drug Discovery! Axcelead oligonucleotide drug discovery services are designed to accelerate your oligonucleotide drug project with our comprehensive platform. Whether you are in the pharmaceutical, biotechnology, or academic sector, our comprehensive solutions can help you achieve your scientific goals more efficiently. - [Cardiovascular / Metabolic disease](https://axcelead-us.com/therapeutic-areas/cardiovascular-metabolic-disease/): Therapeutic Areas Cardiovascular / Metabolic Disease At Axcelead, we have extensive experience and know-how in the preclinical development of new... - [Thank you inquiry](https://axcelead-us.com/thank-you-inquiry/): Contact Us For questions and consultations about our business and services, please use the form below. Thank you for your... - [Previous Conferences](https://axcelead-us.com/events/previous-conferences/): Welcome to view the conferences that Axcelead Drug Discovery Partners, Inc. has attended. - [Oncology](https://axcelead-us.com/therapeutic-areas/oncology/): Therapeutic Areas Advancing Oncology Research We have a long and proven track record in the development of small molecules for... - [IND-enabling](https://axcelead-us.com/integrated-drug-discovery/ind-enabling/): Axcelead offers refined IND enabling services to accelerate your drug discovery process. Our experienced and collaborative team supports your IND enabling projects with professional expertise and state-of-the-art facilities, delivering timely and cost-effective results. - [Neuroscience](https://axcelead-us.com/therapeutic-areas/neuroscience/): Therapeutic Areas Advancing Neuroscience Research We understand that developing drugs for neuroscience indications can be challenging. We utilize an integrated... - [Immunology](https://axcelead-us.com/therapeutic-areas/immunology/): Therapeutic Areas Advancing Immunology Research We can design and carry out the most appropriate in vitro and/or in vivo studies... - [Future Conferences](https://axcelead-us.com/events/conferences/): Welcome to view the conferences that Axcelead Drug Discovery Partners, Inc. will be attending. - [Previous Seminars](https://axcelead-us.com/events/previous-seminars/): Welcome to view the seminars that Axcelead Drug Discovery Partners, Inc. has held. - [Future Seminars](https://axcelead-us.com/events/seminars/): Welcome to view the seminars that Axcelead Drug Discovery Partners, Inc. will be holding. - [Candidate Selection](https://axcelead-us.com/integrated-drug-discovery/candidate-selection/): Axcelead offers refined candidate selection services to accelerate your drug discovery process. Our experienced and collaborative team supports your candidate selection projects with professional expertise and state-of-the-art facilities, delivering timely and cost-effective results. - [Lead Generation / Optimization](https://axcelead-us.com/integrated-drug-discovery/lead-generation-optimization/): Axcelead offers refined lead generation and optimization services to accelerate your drug discovery process. Our experienced and collaborative team supports your lead generation and optimization projects with professional expertise, state-of-the-art facilities, and a large compound library/database originating from the pharmaceutical industry, delivering timely and cost-effective results. - [Hit Identification / Characterization](https://axcelead-us.com/integrated-drug-discovery/hit-identification-characterization/): Axcelead offers refined hit identification and characterization services to accelerate your drug discovery process. Our experienced and collaborative team supports your hit identification and characterization projects with professional expertise, state-of-the-art facilities, and a large compound library/database originating from the pharmaceutical industry, delivering timely and cost-effective results. - [Integrated Drug Discovery](https://axcelead-us.com/integrated-drug-discovery/): Axcelead offers integrated drug discovery and development solutions to clients worldwide, including academia, biotechnology, and pharmaceutical companies. Our experienced team works closely with you at every step of your drug discovery project, from target identification, hit identification and characterization, lead generation and optimization, and candidate selection to IND enabling and beyond. - [Target Identification / Validation](https://axcelead-us.com/integrated-drug-discovery/target-identification-validation/): Axcelead offers refined target identification and validation services to accelerate your drug discovery process. Our experienced and collaborative team supports your target identification and validation projects with professional expertise, state-of-the-art facilities, and a large compound library/database originating from the pharmaceutical industry, delivering timely and cost-effective results. - [Contact Us](https://axcelead-us.com/contact-us/): Contact Us For questions and consultations about our business and services, please use the form below. PGlmcmFtZSBzcmM9Imh0dHBzOi8vZ28uYXhjZWxlYWQuY29tL2wvOTk2MjYxLzIwMjItMTAtMDgvMndrZyIgd2lkdGg9IjEwMCUiIGhlaWdodD0iMTU1MCIgdHlwZT0idGV4dC9odG1sIiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dUcmFuc3BhcmVuY3k9InRydWUiIHN0eWxlPSJib3JkZXI6IDAiPjwvaWZyYW1lPg== Contact Us Please... - [Presentations](https://axcelead-us.com/resources/presentations/): Presentations PHNjcmlwdD4Kc2V0VGltZW91dChmdW5jdGlvbigpIHsKICBqUXVlcnkoZG9jdW1lbnQpLnJlYWR5KGZ1bmN0aW9uKCQpIHsgCgkkKCIuZnVzaW9uLXZlcnRpY2FsLW1lbnUtd2lkZ2V0IHVsIGxpIikuZWFjaChmdW5jdGlvbigpewoJCWxpbmtBbm51YWwgPSAkKCJhIiwgJCh0aGlzKSk7IAogICAgICAgIG9yaWdpbmFsSHJlZiA9ICQobGlua0FubnVhbCkuYXR0cigiaHJlZiIpOwogICAgICAgICQobGlua0FubnVhbCkuYXR0cigiaHJlZiIsIG9yaWdpbmFsSHJlZiArICI/Y2F0PTE4Iik7IC8vIFByZXNlbnRhdGlvbiBjYXRlZ29yeQogICAgfSk7CiAgfSk7Cn0sIDgwMCk7Cjwvc2NyaXB0Pg== - [Posters](https://axcelead-us.com/resources/posters/): Posters PHNjcmlwdD4Kc2V0VGltZW91dChmdW5jdGlvbigpIHsKICBqUXVlcnkoZG9jdW1lbnQpLnJlYWR5KGZ1bmN0aW9uKCQpIHsgCgkkKCIuZnVzaW9uLXZlcnRpY2FsLW1lbnUtd2lkZ2V0IHVsIGxpIikuZWFjaChmdW5jdGlvbigpewoJCWxpbmtBbm51YWwgPSAkKCJhIiwgJCh0aGlzKSk7IAogICAgICAgIG9yaWdpbmFsSHJlZiA9ICQobGlua0FubnVhbCkuYXR0cigiaHJlZiIpOwogICAgICAgICQobGlua0FubnVhbCkuYXR0cigiaHJlZiIsIG9yaWdpbmFsSHJlZiArICI/Y2F0PTE5Iik7IC8vIFByZXNlbnRhdGlvbiBjYXRlZ29yeQogICAgfSk7CiAgfSk7Cn0sIDUwMCk7Cjwvc2NyaXB0Pg== - [News](https://axcelead-us.com/news/): News Latest News and Press Releases 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 - [Brochures](https://axcelead-us.com/resources/brochures/): Company Introduction 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 Integrated Drug Discovery 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 Therapeutic Areas 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 Technology Platforms 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 Therapeutic Modalities PHNjcmlwdD4Kc2V0SW50ZXJ2YWwoZnVuY3Rpb24oKSB7CiAgalF1ZXJ5KGRvY3VtZW50KS5yZWFkeShmdW5jdGlvbigkKSB7IAoJJCgnLm1ldGEtdGFncycpLmNvbnRlbnRzKCkuZmlsdGVyKGZ1bmN0aW9uKCkgewogICAgICAgIHJldHVybiB0aGlzLm5vZGVUeXBlID09PSAzOyAvLyBGaWx0ZXIgb3V0IHRleHQgbm9kZXMKICAgIH0pLnJlbW92ZSgpOwoKCSQoIi5wb3N0ZXJzLWJsb2cgYXJ0aWNsZSIpLmVhY2goZnVuY3Rpb24oKXsKCQltZXRhVGFnID0gJCgiLmZ1c2lvbi1zaW5nbGUtbGluZS1tZXRhIiwgJCh0aGlzKSk7CgkJcG9zdFRpdGxlID0gJCgiZGl2LmVudHJ5LXRpdGxlIiwgJCh0aGlzKSk7IAoKCQkkKG1ldGFUYWcpLmluc2VydEJlZm9yZSgkKHBvc3RUaXRsZSkpOwogICAgfSk7CiAgICAgCiAgfSk7Cn0sIDUwMCk7Cjwvc2NyaXB0Pgo8c3R5bGU+CmRpdi5lbnRyeS10aXRsZSBhIHsKICBjb2xvcjogIzAwMDsKfSAKZGl2LmVudHJ5LXRpdGxlIGE6aG92ZXIgewogIGNvbG9yOiB2YXIoLS1tYWlucmVkKSFpbXBvcnRhbnQ7Cn0gCi5mdXNpb24tc2luZ2xlLWxpbmUtbWV0YSB7CiAgICBtYXJnaW4tdG9wOiAwcHg7CiAgICBmb250LXNpemU6IDE2cHg7CiAgICBib3JkZXI6IG5vbmU7CiAgICB0ZXh0LXRyYW5zZm9ybTogdXBwZXJjYXNlOwogICAgbWFyZ2luLWJvdHRvbTogOHB4IWltcG9ydGFudDsKICAgIGZvbnQtd2VpZ2h0OiA1MDA7CiAgICBwb2ludGVyLWV2ZW50czogbm9uZTsKICAgY29sb3I6IHZhcigtLW1haW5ncmVlbik7Cn0KLmZ1c2lvbi1ibG9nLWxheW91dC1ncmlkIC5mdXNpb24tcG9zdC1jb250ZW50LWNvbnRhaW5lcnsKICAgIG1hcmdpbi10b3A6IDI1cHg7Cn0KLmZ1c2lvbi1ibG9nLWxheW91dC1ncmlkLmZ1c2lvbi1ibG9nLWVxdWFsLWhlaWdodHMgLmZ1c2lvbi1wb3N0LXdyYXBwZXIgewogICAgYm9yZGVyLWJvdHRvbTogMnB4IHNvbGlkIHZhcigtLW1haW5ncmF5KSFpbXBvcnRhbnQ7CiAgcGFkZGluZzogMzBweCAxMHB4IDAhaW1wb3J0YW50OwogIHBvc2l0aW9uOiByZWxhdGl2ZTsKfQoucG9zdGVycy1ibG9nIC5mdXNpb24tYmxvZy1sYXlvdXQtZ3JpZCAuZnVzaW9uLXBvc3QtZ3JpZCB7CiAgICBwYWRkaW5nOiAyMHB4OwogICAgbWluLWhlaWdodDogMjAwcHg7Cn0KYXJ0aWNsZSAuZG93bmxvYWQtcGRmLXdyYXAgewogICAgbWFyZ2luLXRvcDogMzBweDsKICBwb3NpdGlvbjogYWJzb2x1dGU7CiAgYm90dG9tOiAyMHB4Cn0KLmZ1c2lvbi1ib2R5IC5mdXNpb24tbG9hZC1tb3JlLWJ1dHRvbiB7CiAgICBmb250LXdlaWdodDogNjAwOwogICAgd2lkdGg6IGF1dG8haW1wb3J0YW50OwogICAgbWFyZ2luOiBhdXRvOwogICAgcGFkZGluZzogMHB4IDQwcHg7CiAgICBib3JkZXItcmFkaXVzOiA2cHg7CiAgICBiYWNrZ3JvdW5kOiAjNGJiMjM0IWltcG9ydGFudDsKICBtYXJnaW4tdG9wOiA2MHB4Owp9Ci5mdXNpb24tYm9keSAuZnVzaW9uLWxvYWQtbW9yZS1idXR0b246aG92ZXIgewogICAgYmFja2dyb3VuZDogI2FmMDA0MCFpbXBvcnRhbnQ7Cn0KQG1lZGlhIG9ubHkgc2NyZWVuIGFuZCAobWF4LXdpZHRoOiA4MDBweCl7CiAgLmZ1c2lvbi1ibG9nLWxheW91dC1ncmlkIC5mdXNpb24tcG9zdC1ncmlkIHsKICAgIHBhZGRpbmc6IDIwcHggMCFpbXBvcnRhbnQ7CiAgfQogIC5mdXNpb24tYmxvZy1sYXlvdXQtZ3JpZC5mdXNpb24tYmxvZy1lcXVhbC1oZWlnaHRzIC5mdXNpb24tcG9zdC13cmFwcGVyIHsKICAgIHBhZGRpbmc6IDBweCAwcHggMCFpbXBvcnRhbnQ7CiAgfQogICN3cmFwcGVyICNtYWluIC5mdXNpb24tYmxvZy1zaG9ydGNvZGUgLmVudHJ5LXRpdGxlLCAKICAuZnVzaW9uLWJsb2ctc2hvcnRjb2RlIC5lbnRyeS10aXRsZSB7CiAgICBmb250LXNpemU6IDE3cHghaW1wb3J0YW50OwogIH0KICAucG9zdGVycy1ibG9nIC5mdXNpb24tYmxvZy1sYXlvdXQtZ3JpZCAuZnVzaW9uLXBvc3QtZ3JpZCB7CiAgICBtaW4taGVpZ2h0OiAxNjBweDsKfQp9Cjwvc3R5bGU+ - [Publications](https://axcelead-us.com/resources/publications/): Publications 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 - [Videos](https://axcelead-us.com/resources/videos/): Targeted Protein Degradation 1 Minute Guide for HTS Platform Global Webinar Hot Topics Screening Capabilities 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 - [Cookie Policy](https://axcelead-us.com/cookie-policy/): Policies Cookie Policy2021/05/27 About Cookies Cookies are data stored directly on your computer. They are used to gather information such... - [Test Page with Mega Menu](https://axcelead-us.com/test-page-with-mega-menu/): The Future of Drug Discovery is Here. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt... - [Privacy Policy: Personal Information Protection Policy](https://axcelead-us.com/privacy-policy-personal-information-protection-policy/): Policies Privacy Policy: Personal Information Protection Policy １． Policy Axcelead Drug Discovery Partners Inc. (the “Company”), in order to appropriately... - [About Us](https://axcelead-us.com/about-us/): About Us We are pioneering the future of drug discovery. https://axcelead-us. com/wp-content/uploads/2023/12/whoweare-topimage2. jpg Who We Are Axcelead is your trusted... - [Privacy Policy](https://axcelead-us.com/privacy-policy/): Policies Privacy Policy Axcelead Group has established a basic policy for the handling of personal information, and will comply with... --- --- ## Posts - [SLAS2026 International Conference & Exhibition](https://axcelead-us.com/future-conferences/slas2026/): Boston, MA - [Biotech Showcase 2026](https://axcelead-us.com/future-conferences/biotech-showcase-2026/): San Francisco, CA - [Research article on advanced mass spectrometry analysis of disease-associated Asn-linked glycoconjugates in NGLY1 deficiency has been published](https://axcelead-us.com/topics/research-article-on-advanced-mass-spectrometry-analysis/): Structural characterization and insights into the formation of N-acetylglucosaminylasparagine and its derivatives in NGLY1-deficient models and patients Publication Published Date... - [Axcelead DDP Signs an Agreement with Astellas for HT-ADMET Studies](https://axcelead-us.com/news/axcelead-ddp-signs-an-agreement-with-astellas/): Fujisawa, Japan, December 11, 2025 – Axcelead Drug Discovery Partners, Inc. (President & CEO: Kengo Okada, Ph. D. ; hereinafter... - [Evaluation of γH2AX Assay for Screening Chromosomal Aberrations](https://axcelead-us.com/posters/evaluation-of-%ce%b3h2ax-assay-for-screening-chromosomal-aberrations/): The 54th Annual Meeting of JapaneseEnvironmental Mutagen and Genome Society (JEMS) Download - [Research Article on Exon Skipping in Alport Syndrome Mouse Model Published in Scientific Reports](https://axcelead-us.com/topics/research-article-on-exon-skipping-in-alport-syndrome-mouse-model/): Podocyte specific exon skipping after disease onset improves kidney pathology and function in a mouse model of Alport syndrome Publication... - [Podocyte specific exon skipping after disease onset improves kidney pathology and function in a mouse model of Alport syndrome](https://rdcu.be/eRJHG): Scientific Reports - [Research article on pharmacological evaluation using a MASH mouse model has been published in Scientific Reports](https://axcelead-us.com/topics/publication-in-scientific-reports/): Differences between Therapeutic Mechanisms of Resmetirom and Semaglutide against MASH in Western Diet-Fed MC4R-Knockout Mice Publication Published Date : November... - [Differences between Therapeutic Mechanisms of Resmetirom and Semaglutide against MASH in Western Diet-Fed MC4R-Knockout Mice](https://www.nature.com/articles/s41598-025-24927-3): Scientific Reports - [Participation in the 16th Annual Conference on Biomolecular Screenology – Exhibition Booth and Corporate Seminar](https://axcelead-us.com/topics/participation-in-the-16th-cbs/): Conference Name: the 16th Conference on Biomolecular Screenology Axcelead will exhibit a corporate booth and host a seminar at the... - [DMPK Services](https://axcelead-us.com/brochures/dmpk-services/): Download - [Researcher Yamasaki from DMPK BU to Present a Poster at the 16th Annual Conference on Biomolecular Screenology](https://axcelead-us.com/topics/yamasaki-to-present-a-poster-at-16thcbs/): Researcher Yamasaki from the DMPK Business Unit, will deliver a poster presentation at the 16th Annual Conference of Conference on... - [Researcher Shirai from DMPK BU to Deliver an Oral Presentation at the 16th Annual Conference on Biomolecular Screenology](https://axcelead-us.com/topics/shirai-oral-presentation-at-16thcbs/): Researcher Shirai from the DMPK Business Unit, will deliver a oral presentation at the 16th Annual Conference of Conference on... - [Anti-Obese Effects of GLP-1 Related Peptides on MC4R Deficient Mice and Nauseous Experiment Systems](https://axcelead-us.com/posters/anti-obese-effects-of-glp-1-related-peptides-on-mc4r-deficient-mice-and-nauseous-experiment-systems/): ObesityWeek® 2025 Download - [Researcher Yoshida from Safety BU to Present a Poster at the 54th Annual Meeting of Japanese Environmental Mutagen and Genome Society (JEMS)](https://axcelead-us.com/topics/yoshida-to-present-a-poster-at-jems54th/): Researcher Yoshida from the Safety Business Unit, will deliver a poster presentation at the 54th Annual Meeting of the Japanese... - [Axcelead DDP Enters into Contract Research Agreement with RealizeEdge Partners for the Creation of Candidate Compounds Targeting Specific Proteins](https://axcelead-us.com/news/contract-research-agreement-with-realizeedge-partners/): Fujisawa, Japan, November 11, 2025 – Axcelead Drug Discovery Partners, Inc. (Head Office: Fujisawa City, Kanagawa Prefecture; Representative Director, President... - [DAR evaluation in mouse plasma using anti-human IgG immunocapture and intact mass spectrometry at the discovery stage](https://axcelead-us.com/posters/dar-evaluation-in-mouse-plasma-using-anti-human-igg-immunocapture-and-intact-mass-spectrometry-at-the-discovery-stage/): The 40th Annual Meeting of the Japanese Society for the Study of Xenobiotics Download - [Development of drug metabolism method by human microbiome](https://axcelead-us.com/posters/development-of-drug-metabolism-method-by-human-microbiome/): The 40th Annual Meeting of the Japanese Society for the Study of Xenobiotics Download - [Exhibiting at the 42nd Medicinal Chemistry Symposium](https://axcelead-us.com/topics/exhibiting-at-the-42nd-medicinal-chemistry-symposium/): Conference Name: the 42nd Medicinal Chemistry Symposium Date: November 18-20, 2025 (JST) Location: Awagin Hall (2-14 Aibacho, Tokushima City, Tokushima... - [Immune Cell function and Effect of Immune Checkpoint Inhibitor in Freshly Dispersed Human Tumors](https://axcelead-us.com/posters/poster-unno-jca2025/): The 84th Annual Meeting of the Japanese Cancer Association Download - [Establishment of a TME-resembling in vitro assay system using freshly isolated human tumoroids](https://axcelead-us.com/posters/poster-tabata-jca8th/): The 84th Annual Meeting of the Japanese Cancer Association Download - [BIO-Europe 2025](https://axcelead-us.com/previous-conferences/bio-europe-2025/): Vienna, Austria - [Dr. Nio from Pharmacology BU to Present a Poster at ObesityWeek® 2025](https://axcelead-us.com/topics/dr-nio-at-obesityweek-2025/): Dr. Yasunori Nio from the Pharmacology Business Unit, will deliver a poster presentation at ObesityWeek® 2025, to be held in... - [Maximizing Human Predictability from In Vivo Pharmacology Studies](https://axcelead-us.com/previous-seminars/in-vivo-pharmacology-studies/): Join this webinar to find out how we can help accelerate your Drug Discovery! our first speaker will provide an... - [Exhibit at the 40th Annual Meeting of the Japanese Society for the Study of Xenobiotics](https://axcelead-us.com/topics/exhibit-at-jssx40/): Conference Name: the 40th Annual Meeting of the Japanese Society for the Study of Xenobiotics Date: October 20-23, 2025 (JST)... - [NAMs Empower Translational Research](https://axcelead-us.com/previous-seminars/nams-empower-translational-research/): Join this webinar to find out how we can help accelerate your Drug Discovery! This webinar will provide three key... - [Researcher Asano from DMPK BU to deliver Presentation about Spatial Transcriptomics at the 40th Annual Meeting of the Japanese Society for the Study of Xenobiotics](https://axcelead-us.com/topics/researcher-asano-present-jssx40/): Our researcher, Shinya Asano from the DMPK Business Unit, will deliver an invited presentation about spatial transcriptomics at the 40th... - [Pharmacology BU researcher Kusano will present at a symposium hosted by the Japan Association for Laboratory Animal Science](https://axcelead-us.com/topics/researcher-kusano-presentation-at-jalas/): Our researcher, Kaori Kusano from the Pharmacology Business Unit, will deliver an oral presentation at the Japan Association for Laboratory... - [Researcher Kushal Rugjee from Screening BU to Present a Poster at ELRIG’s Drug Discovery 2025](https://axcelead-us.com/topics/researcher-kushal-rugjee-from-screening-bu-to-present-a-poster-at-elrigs-drug-discovery-2025/): Our researcher, Kushal Rugjee from the Screening Business Unit, will deliver an poster presentation at ELRIG’s Drug Discovery 2025, to... - [Structural characterization and insights into the formation of N-acetylglucosaminylasparagine and its derivatives in NGLY1-deficient models and patients](https://rdcu.be/eRJHG): Glycobiology - [Researcher Nagasaka from DMPK BU to Present a Poster at the 40th Annual Meeting of the Japanese Society for the Study of Xenobiotics](https://axcelead-us.com/topics/researcher-nagasaka-present-a-poster-jssx40/): Our researcher, Kosuke Nagasaka from the DMPK Business Unit, will present a poster at the 40th Annual Meeting of the... - [Researcher Nonaka from DMPK BU to Present a Poster at the 40th Annual Meeting of the Japanese Society for the Study of Xenobiotics](https://axcelead-us.com/topics/researcher-nonaka-present-a-poster-jssx40/): Our researcher, Masami Nonaka from the DMPK Business Unit, will present a poster at the 40th Annual Meeting of the... - [Strategic Drug Discovery Support through Integrated Utilization of Preclinical Models to Enhance Human Clinical Translatability](https://axcelead-us.com/presentations/strategic-drug-discovery-support-through-integrated-utilization-of-preclinical-models-to-enhance-human-clinical-translatability/): In-Vivo Science Symposium Download - [Axcelead DDP to Exhibit at Bio Japan 2025](https://axcelead-us.com/topics/bio-japan-2025/): Conference Name: Bio Japan 2025 Time: October 8-10, 2025 Venue: Pacifico Yokohama, Kanagawa, Japan Booth No. : D-27 Axcelead Drug... - [xFOREST Therapeutics and Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug Discovery](https://axcelead-us.com/news/xforest-axcelead-launch-joint-research/): Kyoto and Kanagawa, Japan, September 18, 2025 – xFOREST Therapeutics Co. , Ltd. (“xFOREST”) and Axcelead Drug Discovery Partners, Inc.... - [Dr. Kai from Safety BU to Deliver an Oral Presentation at the 9th Drug Discovery & Lead Optimization Conference](https://axcelead-us.com/topics/dr-kai-presentation-at-9th-drug-discovery-lead-optimization/): Dr. Kiyonori Kai from the Safety Business Unit, will deliver an oral presentation at The 9th Drug discovery & Lead... - [Researcher Tanaka and Ogawa from Pharmacology BU to Present at a symposium hosted by CIEM](https://axcelead-us.com/topics/researcher-tanaka-and-ogawa-presentation-at-symposium/): Our researcher, Hiroshi Tanaka and Masahiro Ogawa from the Pharmacology Business Unit, will give an oral presentation at at a... - [Researcher Tabata from Pharmacology BU to Present a Poster at the 84th Annual Meeting of the Japanese Cancer Association](https://axcelead-us.com/topics/researcher-tabata-to-present-a-poster-at-japanese-cancer-association/): Our researcher, Ryotaro Tabata from the Pharmacology Business Unit, will present a poster at the 84th Annual Meeting of the... - [Axcelead Company Introduction](https://axcelead-us.com/brochures/axcelead-company-introduction/): Download - [Researcher Unno from Pharmacology BU to Present a Poster at the 84th Annual Meeting of the Japanese Cancer Association](https://axcelead-us.com/topics/unno-to-present-a-poster-at-japanese-cancer-association/): Our researcher, Satoko Unno from the Pharmacology Business Unit, will present a poster at the 84th Annual Meeting of the... - [Diverse Approaches to New Chemical Modalities -Challenging the Undruggable Targets beyond Conventional Small Molecule Drug Discovery-](https://axcelead-us.com/previous-seminars/new-chemical-modalities/): Join this webinar to find out how we can help accelerate your Drug Discovery! In this seminar, we will introduce... - [LSX USA Congress 2025](https://axcelead-us.com/previous-conferences/lsx-usa-2025/): Boston, MA - [Nissan Chemical and Axcelead DDP Enter into Business Partnership to Support Drug Discovery Research for RNA Therapeutics](https://axcelead-us.com/news/nissan-chemical/): Tokyo and Kanagawa, Japan, July 18, 2025 — Nissan Chemical Corporation (HQ: Tokyo, Japan; Representative Director, President and COO: Shinsuke... - [PRD Therapeutics Initiates First-in-Human Clinical Trial of SOAT2-Selective Inhibitor ‘PRD001’ — Axcelead DDP Provides Comprehensive Non-Clinical Development Support —](https://axcelead-us.com/topics/prd-therapeutics/): PRD Therapeutics, Inc. (“PRD Therapeutics”), a clinical stage company focused on developing novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia... - [Evaluation of oral exposure increase for poorly soluble compounds with dissolution-improving formulations](https://axcelead-us.com/posters/evaluation-of-oral-exposure-increase-for-poorly-soluble-compounds-with-dissolution-improving-formulations/): The 52nd Annual Meeting of the Japanese Society of Toxicology Download - [Lab-in-the-Loop Hit Discovery: Unlocking ‘Undruggable’ Targets with AI-Powered Hit Identification Platform](https://axcelead-us.com/previous-seminars/lab-in-the-loop-hit-discovery/): Join Axcelead webinar to learn more about the latest technologies and insights in drug discovery and development! - [Development of an Exploratory Renal Toxicity Prediction Method for Oligonucleotide Therapeutics Using Human Proximal Tubule Epithelial Cells](https://axcelead-us.com/posters/development-of-an-exploratory-renal-toxicity-prediction-method-for-oligonucleotide-therapeutics-using-human-proximal-tubule-epithelial-cells/): The 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan Download - [Researcher Oki from Screening BU to Deliver an Oral Presentation at the 52nd Annual Workshop of the Japanese Society of Toxicology](https://axcelead-us.com/topics/oki-presentation-japanese-society-of-toxicology/): Our researcher, Hideyuki Oki from the Screening Business Unit, will deliver an oral presentation at the 52nd Annual Meeting of... - [Researcher Hamada from DMPK BU to Present a Poster at the 52nd Annual Meeting of the Japanese Society of Toxicology](https://axcelead-us.com/topics/hamada-present-japanese-society-of-toxicology/): Our researcher, Teruki Hamada from the DMPK Business Unit, will present a poster at the 52nd Annual Meeting of the... - [Dr. Fukui (Senior Director, Safety BU) to Deliver an Oral Presentation at the 52nd Annual Workshop of the Japanese Society of Toxicology](https://axcelead-us.com/topics/dr-fukui-presentation-at-japanese-society-of-toxicology/): Senior Director and Senior Consultant Dr. Fukui from the Safety Business Unit will deliver an oral presentation at a workshop... - [Axcelead DDP and Superluminal Announce the Intent to Collaborate on Drug Discovery Targeting Specific Molecular Mechanisms, continuing a productive relationship](https://axcelead-us.com/news/superluminal-collaborate-on-drug-discovery/): Kanagawa, Japan and Boston, MA, USA – Jun 23, 2025– Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; “Axcelead... - [Researcher Yoshida from Safety BU to Present a Poster at the 10th Annual Meeting of the Japan Nucleic Acid Therapeutics Society](https://axcelead-us.com/topics/poster_presentation-at-the-japan-nucleic-acid-therapeutics-society/): Our researcher, Ikuma Yoshida from the Safety Business Unit, will present a poster at the 10th Annual Meeting of the... - [LOTTE BIOLOGICS, Axcelead Drug Discovery Partners, Inc., and Kanaph Therapeutics Inc. Sign 3-Way MOU to Develop ADC Toolbox](https://axcelead-us.com/news/sign-3-way-mou-to-develop-adc-toolbox/): - Exploring expansion of ADC services through synergy in ADC modality business via trilateral agreement - Aims to enhance ADC... - [Presentation on Prediction Model for Brain Concentration-Time Profiles of Compounds by Dr. Handa (Digital Unit) at the Structure-Activity Forum 2025](https://axcelead-us.com/topics/the-structure-activity-forum-2025/): Dr. Handa from the Digital Unit will present a prediction model for brain concentration–time profiles of compounds at the Structure–Activity... - [BIO International Convention 2025](https://axcelead-us.com/previous-conferences/bio-international-convention-2025/): Boston, MA - [Comparison of anti-obese effects on GLP-1 analogue peptides, Semaglutide, Tirzepatide and Retatrutide using MC4R deficient obesity model mice](https://axcelead-us.com/posters/comparison-of-anti-obese-effects-on-glp-1-analogue-peptides-semaglutide-tirzepatide-and-retatrutide-using-mc4r-deficient-obesity-model-mice/): ECO 2025（32nd European Congress on Obesity） Download - [Identification of differences in therapeutic mechanisms between Resmetirom and Semaglutide on metabolic dysfunction-associated steatohepatitis treatment in western diet-fed melanocortin 4 receptor knockout mice](https://axcelead-us.com/posters/identification-of-differences-in-therapeutic-mechanisms-between-resmetirom-and-semaglutide-on-metabolic-dysfunction-associated-steatohepatitis-treatment-in-western-diet-fed-melanocortin-4-receptor-kno/): EASL Congress 2025 Download - [Hepatotoxicity Reduction Profiles of Antisense Oligonucleotides Containing Amido-Bridged Nucleic Acid and 2′-O,4′-C-Spirocyclopropylene Bridged Nucleic Acid](https://www.liebertpub.com/doi/10.1089/nat.2024.0047): Nucleic Acid Therapeutics - [The results of joint research with Luxna Biotec, Inc published in "Nucleic Acid Therapeutics"](https://axcelead-us.com/topics/the-results-of-joint-research-with-luxna-biotec-inc-published-in-nucleic-acid-therapeutics/): Hepatotoxicity Reduction Profiles of Antisense Oligonucleotides Containing Amido-Bridged Nucleic Acid and 2′-O,4′-C-Spirocyclopropylene Bridged Nucleic Acid Publication Amide-bridged nucleic acid (AmNA)... - [EASL Congress 2025](https://axcelead-us.com/previous-conferences/easl-congress-2025/): Amsterdam, the Netherlands - [ECO2025 (32nd European Congress on Obesity)](https://axcelead-us.com/previous-conferences/eco2025/): Malaga, Spain - [BIO KOREA 2025](https://axcelead-us.com/previous-conferences/bio-korea-2025/): COEX, Seoul, Korea - [Skeletal muscle and cardiac function in B10-mdx mice​](https://axcelead-us.com/posters/skeletal-muscle-and-cardiac-function-in-b10-mdx-mice/): APPW 2025 in Japan Download - [Drug Discovery Services for Liver Desease](https://axcelead-us.com/brochures/drug-discovery-service-for-liver-desease/): Download - [Identification of covalent JNK inhibitor](https://axcelead-us.com/posters/identification-of-covalent-jnk-inhibitor-2/): Drug Discovery Chemistry 2025 Download - [Research Article Co-Authored on Ferroptosis MoA Analysis Published in Communications Biology](https://axcelead-us.com/topics/research-article-co-authored-on-ferroptosis-moa-analysis-published-in-communications-biology/): Protein covariation networks for elucidating ferroptosis inducer mechanisms and potential synergistic drug targets Publication Mechanism of action (MoA) analysis of... - [Protein covariation networks for elucidating ferroptosis inducer mechanisms and potential synergistic drug targets](https://www.nature.com/articles/s42003-025-07886-3#new_tab): Communications Biology - [Drug Discovery Chemistry 2025](https://axcelead-us.com/previous-conferences/drug-discovery-chemistry-2025/): San Diego, CA - [Evaluation of the effects of GLP1R agonists on MC4R KO hyperphagic obesity model mice](https://axcelead-us.com/posters/evaluation-of-the-effects-of-glp1r-agonists-on-mc4r-ko-hyperphagic-obesity-model-mice/): APPW2025 in Japan Download - [Chemistry Capabilities](https://axcelead-us.com/brochures/chemistry-capabilities/): Download - [Covalent Drug Discovery](https://axcelead-us.com/brochures/covalent-drug-discovery/): Download - [BIO-Europe Spring 2025](https://axcelead-us.com/previous-conferences/bio-europe-spring-2025/): Milan, Italy - [Global Life Science Partnering ＆Investor Conference 2025](https://axcelead-us.com/previous-conferences/global-life-science-partnering-%ef%bc%86investor-conference-2025/): San Diego, CA - [Discovery of mRNA G-quadruplex binders through high-throughtput Affinity Selection Mass Spectrometry screening and comprehensive hit profiling](https://axcelead-us.com/posters/discovery-of-mrna-g-quadruplex-binders-through-high-throughtput-affinity-selection-mass-spectrometry-screening-and-comprehensive-hit-profiling/): SLAS 2025 in San Diego Download - [Accelerate Targeted Protein Degradation Drug Discovery with Axcelead's Integrated Platform, DegLead](https://axcelead-us.com/previous-seminars/accelerate-targeted-protein-degradation-drug-discovery-with-axceleads-integrated-platform-deglead/): Join Axcelead webinar to learn more about the latest technologies and insights in drug discovery and development! - [Axcelead DDP Enters into Drug Discovery Service Agreement with Astellas for Targeted Protein Degraders](https://axcelead-us.com/news/20241226-e-newsrelease/): December 26, 2024 - Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; “Axcelead DDP”) announced today that it has... - [SLAS2025 International Conference & Exhibition](https://axcelead-us.com/previous-conferences/slas2025-international-conference-exhibition/): San Diego, CA - [Identification of covalent JNK inhibitor](https://axcelead-us.com/presentations/identification-of-covalent-jnk-inhibitor-3/): The 41st Medicinal Chemistry Symposium Download - [Identification of covalent JNK inhibitor](https://axcelead-us.com/posters/identification-of-covalent-jnk-inhibitor/): The 41st Medicinal Chemistry Symposium Download - [Comprehensive profiles of the microbiome and metabolome within the gut-liver axis in Western diet-fed MC4R knockout mice](https://axcelead-us.com/posters/comprehensive-profiles-of-the-microbiome-and-metabolome-within-the-gut-liver-axis-in-western-diet-fed-mc4r-knockout-mice/): AASLD The Liver Meeting 2024 Download - [Phosphorylation Dynamics and Kinase Interaction in mRNA Transcription-Associated Kinases: Autophosphorylation of CDK12 and its Modulation by CDK7 and CDK9](https://www.jstage.jst.go.jp/article/bpbreports/7/5/7_170/_article#new_tab): BPB Reports - [AASLD The Liver Meeting 2024](https://axcelead-us.com/previous-conferences/the-liver-meeting-tlm-2024/): San Diego, CA - [Research results of a mouse model of chronic kidney disease (AXCC mice) generated in Axcelead DDP has been published in the American Journal of Pathology as a co-authored article.](https://axcelead-us.com/news/research-results-of-a-mouse-model-of-chronic-kidney-disease-axcc-mice-generated-in-axcelead-ddp-has-been-published-in-the-american-journal-of-pathology-as-a-co-authored-article/): A novel deep learning approach for analyzing glomerular basement membrane lesions in a mouse model of X-linked Alport syndrome Publication... - [Identify Promising Novel Leads: Axcelead's integrated HTS platform powered by computational chemistry and AI/ML](https://axcelead-us.com/previous-seminars/axceleads-integrated-hts-platform-powered-by-computational-chemistry-and-ai-ml/): Join Axcelead webinar to learn more about the latest technologies and insights in drug discovery and development! - [A novel deep learning approach for analyzing glomerular basement membrane lesions in a mouse model of X-linked Alport syndrome](https://ajp.amjpathol.org/article/S0002-9440(24)00368-7/fulltext#new_tab): American Journal of Pathology - [Pharmacology Capabilities](https://axcelead-us.com/brochures/pharmacology-capabilities/): Download - [A Co-authored Paper regarding Immunocompromised type 1 Diabetic Mini-pigs was Published in the Cell Transplantation](https://axcelead-us.com/news/a-co-authored-paper-regarding-immunocompromised-type-1-diabetic-mini-pigs-was-published-in-the-cell-transplantation/): Xenogenic Engraftment of Human Induced Pluripotent Stem Cell–Derived Pancreatic Islet Cells in an Immunosuppressive Diabetic Göttingen Mini-pig Model Publication Transplantation... - [Xenogenic Engraftment of Human-Induced Pluripotent Stem Cell–Derived Pancreatic Islet Cells in an Immunosuppressive Diabetic Göttingen Mini-Pig Model](https://journals.sagepub.com/doi/10.1177/09636897241288932#new_tab): Cell Transplantation - [BIO-Europe 2024](https://axcelead-us.com/previous-conferences/bio-europe-2024/): Stockholm, Sweden - [Axcelead Drug Discovery Partners Enters into Master Service Agreement for Drug Discovery Projects with Acadia Pharmaceuticals](https://axcelead-us.com/news/axcelead-drug-discovery-partners-enters-into-master-service-agreement-for-drug-discovery-projects-with-acadia-pharmaceuticals/): September 10, 2024 - Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; hereinafter referred to as “Axcelead DDP”) announces... - [Axcelead DDP and Lilly Enter into A Research and Collaboration Agreement](https://axcelead-us.com/news/axcelead-ddp-and-lilly-enter-into-research-and-collaboration-agreement/): September 5, 2024 – Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; “Axcelead DDP”) announced today that it has... - [Drug Discovery Services for Neuroscience](https://axcelead-us.com/brochures/drug-discovery-services-for-neuroscience/): Download - [Neuroscience 2024](https://axcelead-us.com/previous-conferences/neuroscience-2024/): Chicago, IL - [Unique distribution of antisense oligonucleotidesin the brain by the intrathecal administration](https://axcelead-us.com/posters/unique-distribution-of-antisense-oligonucleotidesin-the-brain-by-the-intrathecal-administration/): The 9th Annual Meeting of the Nucleic Acid Therapeutics Society of Japan Download - [Axcelead Kinase Inhibitor Discovery Platform: Identification of Selective Inhibitors for 123 Kinases](https://axcelead-us.com/presentations/axcelead-kinase-inhibitor-discovery-platform-identification-of-selective-inhibitors-for-123-kinases/): Discovery on Target 2023 Sponsored Presentation Download - [Immunology Capabilities](https://axcelead-us.com/brochures/immunology-capabilities/): Download - [Cardiovascular/Metabolic Disease Capabilities](https://axcelead-us.com/brochures/cardiovascular-metabolic-disease-capabilities/): Download - [In-silico Technologies for Medicinal Chemistry](https://axcelead-us.com/brochures/in-silico-technologies-for-medicinal-chemistry/): Download - [Innovative RNA-targeting Small Molecules](https://axcelead-us.com/brochures/innovative-rna-targeting-small-molecules/): Download - [Axcelead DDP has become a certified provider of Single Cell Gene Expression Solution, from 10x Genomics](https://axcelead-us.com/news/axcelead-ddp-has-become-a-certified-provider-of-single-cell-gene-expression-solution-from-10x-genomics/): We’re delighted to announce that Axcelead Drug Discovery Partners, Inc. (“Axcelead DDP”) has received official certification from 10x Genomics as... - [Drug Discovery Services for Oncology](https://axcelead-us.com/brochures/drug-discovery-services-for-oncology/): Download --- # # Detailed Content ## Pages - Published: 2025-12-08 - Modified: 2025-12-10 - URL: https://axcelead-us.com/integrated-drug-discovery/axcelead-booster/ --- - Published: 2025-08-08 - Modified: 2025-11-05 - URL: https://axcelead-us.com/ --- - Published: 2025-08-08 - Modified: 2025-08-07 - URL: --- > Axcelead High Throughput Screening services are designed to help you create truly novel, original drugs rapidly with our integrated platform. Whether you're in the pharmaceutical, biotechnology, or academic sector, our comprehensive screening solutions can help you achieve your scientific goals more efficiently. - Published: 2025-07-24 - Modified: 2025-07-24 - URL: https://axcelead-us.com/genetically-modified-animal/ --- > Axcelead High Throughput Screening services are designed to help you create truly novel, original drugs rapidly with our integrated platform. Whether you're in the pharmaceutical, biotechnology, or academic sector, our comprehensive screening solutions can help you achieve your scientific goals more efficiently. - Published: 2025-06-09 - Modified: 2025-06-09 - URL: https://axcelead-us.com/bioinformatics/ --- - Published: 2025-05-21 - Modified: 2025-05-21 - URL: https://axcelead-us.com/topics/ --- - Published: 2025-05-21 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news-releases/ --- > Axcelead High Throughput Screening services are designed to help you create truly novel, original drugs rapidly with our integrated platform. Whether you're in the pharmaceutical, biotechnology, or academic sector, our comprehensive screening solutions can help you achieve your scientific goals more efficiently. - Published: 2025-05-21 - Modified: 2025-05-29 - URL: https://axcelead-us.com/omics/ --- > Axcelead Chemistry services are designed to help you create the medicines of the future. Whether you're in the pharmaceutical, biotechnology, or academic sector, our comprehensive chemistry solutions can help you achieve your scientific goals more efficiently. - Published: 2024-12-13 - Modified: 2024-12-13 - URL: https://axcelead-us.com/chemistry/ --- > Axcelead is your partner in Targeted Protein Degradation Drug Discovery! Axcelead has comprehensive capabilities in Targeted Protein Degradation Drug Discovery drug discovery at the preclinical stages and a proven track record. Whether you are in the pharmaceutical, biotechnology, or academic sector, our comprehensive solutions can help you achieve your scientific goals more efficiently. - Published: 2024-12-13 - Modified: 2024-12-13 - URL: https://axcelead-us.com/small-molecules/ --- > Axcelead is your partner in Targeted Protein Degradation Drug Discovery! Axcelead has comprehensive capabilities in Targeted Protein Degradation Drug Discovery drug discovery at the preclinical stages and a proven track record. Whether you are in the pharmaceutical, biotechnology, or academic sector, our comprehensive solutions can help you achieve your scientific goals more efficiently. - Published: 2024-11-14 - Modified: 2024-12-20 - URL: https://axcelead-us.com/targeted-protein-degraders/ --- > Axcelead is your partner in RNA-Targeted Drug Discovery! Axcelead has comprehensive capabilities in integrated RNA-targeted small molecule drug discovery at the preclinical stages. Whether you are in the pharmaceutical, biotechnology, or academic sector, our comprehensive solutions can help you achieve your scientific goals more efficiently. - Published: 2024-11-14 - Modified: 2024-12-18 - URL: https://axcelead-us.com/rna-targeted-small-molecules/ --- > Axcelead is your partner in Peptide Drug Discovery! Axcelead peptide drug discovery services are designed to accelerate your peptide drug project with our comprehensive platform. Whether you are in the pharmaceutical, biotechnology, or academic sector, our comprehensive solutions can help you achieve your scientific goals more efficiently. - Published: 2024-08-08 - Modified: 2024-12-03 - URL: https://axcelead-us.com/peptide/ --- > Axcelead High Throughput Screening services are designed to help you create truly novel, original drugs rapidly with our integrated platform. Whether you're in the pharmaceutical, biotechnology, or academic sector, our comprehensive screening solutions can help you achieve your scientific goals more efficiently. - Published: 2024-07-17 - Modified: 2024-12-18 - URL: https://axcelead-us.com/high-throughput-screening/ --- > Axcelead is your partner in Oligonucleotide Drug Discovery! Axcelead oligonucleotide drug discovery services are designed to accelerate your oligonucleotide drug project with our comprehensive platform. Whether you are in the pharmaceutical, biotechnology, or academic sector, our comprehensive solutions can help you achieve your scientific goals more efficiently. - Published: 2024-07-17 - Modified: 2025-06-03 - URL: https://axcelead-us.com/oligonucleotide/ --- - Published: 2024-05-08 - Modified: 2024-12-11 - URL: https://axcelead-us.com/therapeutic-areas/cardiovascular-metabolic-disease/ --- - Published: 2024-01-04 - Modified: 2024-01-04 - URL: https://axcelead-us.com/thank-you-inquiry/ --- > Welcome to view the conferences that Axcelead Drug Discovery Partners, Inc. has attended. - Published: 2023-12-19 - Modified: 2024-05-24 - URL: https://axcelead-us.com/events/previous-conferences/ --- - Published: 2023-12-13 - Modified: 2024-05-27 - URL: https://axcelead-us.com/therapeutic-areas/oncology/ --- > Axcelead offers refined IND enabling services to accelerate your drug discovery process. Our experienced and collaborative team supports your IND enabling projects with professional expertise and state-of-the-art facilities, delivering timely and cost-effective results. - Published: 2023-12-13 - Modified: 2024-06-17 - URL: https://axcelead-us.com/integrated-drug-discovery/ind-enabling/ --- - Published: 2023-12-13 - Modified: 2024-10-22 - URL: https://axcelead-us.com/therapeutic-areas/neuroscience/ --- - Published: 2023-12-13 - Modified: 2024-01-05 - URL: https://axcelead-us.com/therapeutic-areas/immunology/ --- > Welcome to view the conferences that Axcelead Drug Discovery Partners, Inc. will be attending. - Published: 2023-12-09 - Modified: 2024-05-24 - URL: https://axcelead-us.com/events/conferences/ --- > Welcome to view the seminars that Axcelead Drug Discovery Partners, Inc. has held. - Published: 2023-12-09 - Modified: 2024-05-24 - URL: https://axcelead-us.com/events/previous-seminars/ --- > Welcome to view the seminars that Axcelead Drug Discovery Partners, Inc. will be holding. - Published: 2023-12-09 - Modified: 2024-05-24 - URL: https://axcelead-us.com/events/seminars/ --- > Axcelead offers refined candidate selection services to accelerate your drug discovery process. Our experienced and collaborative team supports your candidate selection projects with professional expertise and state-of-the-art facilities, delivering timely and cost-effective results. - Published: 2023-12-09 - Modified: 2024-06-17 - URL: https://axcelead-us.com/integrated-drug-discovery/candidate-selection/ --- > Axcelead offers refined lead generation and optimization services to accelerate your drug discovery process. Our experienced and collaborative team supports your lead generation and optimization projects with professional expertise, state-of-the-art facilities, and a large compound library/database originating from the pharmaceutical industry, delivering timely and cost-effective results. - Published: 2023-12-09 - Modified: 2024-12-18 - URL: https://axcelead-us.com/integrated-drug-discovery/lead-generation-optimization/ --- > Axcelead offers refined hit identification and characterization services to accelerate your drug discovery process. Our experienced and collaborative team supports your hit identification and characterization projects with professional expertise, state-of-the-art facilities, and a large compound library/database originating from the pharmaceutical industry, delivering timely and cost-effective results. - Published: 2023-12-09 - Modified: 2025-02-07 - URL: https://axcelead-us.com/integrated-drug-discovery/hit-identification-characterization/ --- > Axcelead offers integrated drug discovery and development solutions to clients worldwide, including academia, biotechnology, and pharmaceutical companies. Our experienced team works closely with you at every step of your drug discovery project, from target identification, hit identification and characterization, lead generation and optimization, and candidate selection to IND enabling and beyond. - Published: 2023-12-09 - Modified: 2024-06-17 - URL: https://axcelead-us.com/integrated-drug-discovery/ --- > Axcelead offers refined target identification and validation services to accelerate your drug discovery process. Our experienced and collaborative team supports your target identification and validation projects with professional expertise, state-of-the-art facilities, and a large compound library/database originating from the pharmaceutical industry, delivering timely and cost-effective results. - Published: 2023-12-09 - Modified: 2024-06-17 - URL: https://axcelead-us.com/integrated-drug-discovery/target-identification-validation/ --- - Published: 2023-12-04 - Modified: 2024-02-29 - URL: https://axcelead-us.com/contact-us/ --- - Published: 2023-11-30 - Modified: 2024-06-05 - URL: https://axcelead-us.com/resources/presentations/ --- - Published: 2023-11-30 - Modified: 2023-12-21 - URL: https://axcelead-us.com/resources/posters/ --- - Published: 2023-11-30 - Modified: 2024-01-04 - URL: https://axcelead-us.com/news/ --- - Published: 2023-11-30 - Modified: 2025-09-17 - URL: https://axcelead-us.com/resources/brochures/ --- - Published: 2023-11-30 - Modified: 2023-12-16 - URL: https://axcelead-us.com/resources/publications/ --- - Published: 2023-11-30 - Modified: 2024-02-27 - URL: https://axcelead-us.com/resources/videos/ --- - Published: 2023-11-29 - Modified: 2024-01-04 - URL: https://axcelead-us.com/cookie-policy/ --- - Published: 2023-11-29 - Modified: 2023-11-29 - URL: https://axcelead-us.com/test-page-with-mega-menu/ --- - Published: 2023-11-29 - Modified: 2023-12-16 - URL: https://axcelead-us.com/privacy-policy-personal-information-protection-policy/ --- - Published: 2023-11-16 - Modified: 2025-11-30 - URL: https://axcelead-us.com/about-us/ --- - Published: 2023-11-06 - Modified: 2024-01-04 - URL: https://axcelead-us.com/privacy-policy/ --- --- --- ## Posts - Published: 2026-01-13 - Modified: 2026-01-13 - URL: https://axcelead-us.com/future-conferences/slas2026/ - Categories: Future Conferences Boston, MA --- - Published: 2025-12-22 - Modified: 2025-12-22 - URL: https://axcelead-us.com/future-conferences/biotech-showcase-2026/ - Categories: Future Conferences San Francisco, CA --- - Published: 2025-12-17 - Modified: 2025-12-17 - URL: https://axcelead-us.com/topics/research-article-on-advanced-mass-spectrometry-analysis/ - Categories: News, Topics --- - Published: 2025-12-11 - Modified: 2025-12-10 - URL: https://axcelead-us.com/news/axcelead-ddp-signs-an-agreement-with-astellas/ - Categories: News, News Releases --- - Published: 2025-12-05 - Modified: 2025-12-04 - URL: https://axcelead-us.com/topics/research-article-on-exon-skipping-in-alport-syndrome-mouse-model/ - Categories: News, Topics --- - Published: 2025-11-21 - Modified: 2025-12-01 - URL: https://axcelead-us.com/topics/publication-in-scientific-reports/ - Categories: News, Topics --- - Published: 2025-11-20 - Modified: 2025-11-19 - URL: https://axcelead-us.com/topics/participation-in-the-16th-cbs/ - Categories: Topics --- - Published: 2025-11-18 - Modified: 2025-11-27 - URL: https://axcelead-us.com/topics/yamasaki-to-present-a-poster-at-16thcbs/ - Categories: Topics --- - Published: 2025-11-18 - Modified: 2025-11-20 - URL: https://axcelead-us.com/topics/shirai-oral-presentation-at-16thcbs/ - Categories: Topics --- - Published: 2025-11-11 - Modified: 2025-11-11 - URL: https://axcelead-us.com/topics/yoshida-to-present-a-poster-at-jems54th/ - Categories: Topics --- - Published: 2025-11-11 - Modified: 2025-11-11 - URL: https://axcelead-us.com/news/contract-research-agreement-with-realizeedge-partners/ - Categories: News, News Releases --- - Published: 2025-11-10 - Modified: 2025-11-10 - URL: https://axcelead-us.com/topics/exhibiting-at-the-42nd-medicinal-chemistry-symposium/ - Categories: Topics --- - Published: 2025-10-29 - Modified: 2025-11-12 - URL: https://axcelead-us.com/previous-conferences/bio-europe-2025/ - Categories: Previous Conferences Vienna, Austria --- - Published: 2025-10-24 - Modified: 2025-10-27 - URL: https://axcelead-us.com/topics/dr-nio-at-obesityweek-2025/ - Categories: Topics --- - Published: 2025-10-20 - Modified: 2025-10-23 - URL: https://axcelead-us.com/previous-seminars/in-vivo-pharmacology-studies/ - Categories: Previous Seminars Join this webinar to find out how we can help accelerate your Drug Discovery! our first speaker will provide an overview of these approaches, followed by a case study on anti-obesity drug development presented by our second speaker. --- - Published: 2025-10-20 - Modified: 2025-10-20 - URL: https://axcelead-us.com/topics/exhibit-at-jssx40/ - Categories: Topics --- - Published: 2025-10-19 - Modified: 2025-10-23 - URL: https://axcelead-us.com/previous-seminars/nams-empower-translational-research/ - Categories: Previous Seminars Join this webinar to find out how we can help accelerate your Drug Discovery! This webinar will provide three key technologies relevant to NAMs. These technologies can be introduced prior to IND or clinical studies. --- - Published: 2025-10-17 - Modified: 2025-10-17 - URL: https://axcelead-us.com/topics/researcher-asano-present-jssx40/ - Categories: Topics --- - Published: 2025-10-17 - Modified: 2025-10-17 - URL: https://axcelead-us.com/topics/researcher-kusano-presentation-at-jalas/ - Categories: Topics --- - Published: 2025-10-17 - Modified: 2025-10-17 - URL: https://axcelead-us.com/topics/researcher-kushal-rugjee-from-screening-bu-to-present-a-poster-at-elrigs-drug-discovery-2025/ - Categories: Topics --- - Published: 2025-10-09 - Modified: 2025-10-08 - URL: https://axcelead-us.com/topics/researcher-nagasaka-present-a-poster-jssx40/ - Categories: Topics --- - Published: 2025-10-07 - Modified: 2025-10-06 - URL: https://axcelead-us.com/topics/researcher-nonaka-present-a-poster-jssx40/ - Categories: Topics --- - Published: 2025-09-19 - Modified: 2025-09-19 - URL: https://axcelead-us.com/topics/bio-japan-2025/ - Categories: Topics --- - Published: 2025-09-18 - Modified: 2025-09-18 - URL: https://axcelead-us.com/news/xforest-axcelead-launch-joint-research/ - Categories: News, News Releases --- - Published: 2025-09-18 - Modified: 2025-09-18 - URL: https://axcelead-us.com/topics/dr-kai-presentation-at-9th-drug-discovery-lead-optimization/ - Categories: Topics --- - Published: 2025-09-11 - Modified: 2025-09-11 - URL: https://axcelead-us.com/topics/researcher-tanaka-and-ogawa-presentation-at-symposium/ - Categories: Topics --- - Published: 2025-09-09 - Modified: 2025-09-09 - URL: https://axcelead-us.com/topics/researcher-tabata-to-present-a-poster-at-japanese-cancer-association/ - Categories: Topics --- - Published: 2025-09-04 - Modified: 2025-09-04 - URL: https://axcelead-us.com/topics/unno-to-present-a-poster-at-japanese-cancer-association/ - Categories: Topics --- - Published: 2025-08-22 - Modified: 2025-09-30 - URL: https://axcelead-us.com/previous-seminars/new-chemical-modalities/ - Categories: Previous Seminars Join this webinar to find out how we can help accelerate your Drug Discovery! In this seminar, we will introduce how we are tackling the challenge to create candidate compounds for new chemical modalities. --- - Published: 2025-08-05 - Modified: 2025-10-02 - URL: https://axcelead-us.com/previous-conferences/lsx-usa-2025/ - Categories: Previous Conferences Boston, MA --- - Published: 2025-07-18 - Modified: 2025-07-18 - URL: https://axcelead-us.com/news/nissan-chemical/ - Categories: News, News Releases --- - Published: 2025-07-15 - Modified: 2025-07-15 - URL: https://axcelead-us.com/topics/prd-therapeutics/ - Categories: Topics --- > Join Axcelead webinar to learn more about the latest technologies and insights in drug discovery and development! - Published: 2025-07-11 - Modified: 2025-08-08 - URL: https://axcelead-us.com/previous-seminars/lab-in-the-loop-hit-discovery/ - Categories: Previous Seminars Join this webinar to find out how we can help accelerate your Targeted Protein Degradation Drug Discovery! In this webinar, we will introduce our "DegLead Platform™," an integrated TPD platform, and showcase how our strengths—including specialized chemistry, a comprehensive compound library, diverse assay systems, and advanced ADME solutions—can drive success in your TPD projects. Additionally, we will share application case studies and valuable insights. --- - Published: 2025-06-30 - Modified: 2025-06-30 - URL: https://axcelead-us.com/topics/oki-presentation-japanese-society-of-toxicology/ - Categories: Topics --- - Published: 2025-06-24 - Modified: 2025-06-24 - URL: https://axcelead-us.com/topics/hamada-present-japanese-society-of-toxicology/ - Categories: Topics --- - Published: 2025-06-23 - Modified: 2025-06-23 - URL: https://axcelead-us.com/topics/dr-fukui-presentation-at-japanese-society-of-toxicology/ - Categories: Topics --- - Published: 2025-06-23 - Modified: 2025-06-24 - URL: https://axcelead-us.com/news/superluminal-collaborate-on-drug-discovery/ - Categories: News, News Releases --- - Published: 2025-06-20 - Modified: 2025-06-23 - URL: https://axcelead-us.com/topics/poster_presentation-at-the-japan-nucleic-acid-therapeutics-society/ - Categories: Topics --- - Published: 2025-06-17 - Modified: 2025-06-16 - URL: https://axcelead-us.com/news/sign-3-way-mou-to-develop-adc-toolbox/ - Categories: News, News Releases --- - Published: 2025-06-10 - Modified: 2025-06-23 - URL: https://axcelead-us.com/topics/the-structure-activity-forum-2025/ - Categories: Topics --- - Published: 2025-05-21 - Modified: 2025-06-23 - URL: https://axcelead-us.com/previous-conferences/bio-international-convention-2025/ - Categories: Previous Conferences Boston, MA --- - Published: 2025-04-25 - Modified: 2025-06-24 - URL: https://axcelead-us.com/topics/the-results-of-joint-research-with-luxna-biotec-inc-published-in-nucleic-acid-therapeutics/ - Categories: News, Topics --- - Published: 2025-04-24 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/easl-congress-2025/ - Categories: Previous Conferences Amsterdam, the Netherlands --- - Published: 2025-04-23 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/eco2025/ - Categories: Previous Conferences Malaga, Spain --- - Published: 2025-04-21 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/bio-korea-2025/ - Categories: Previous Conferences COEX, Seoul, Korea --- - Published: 2025-04-08 - Modified: 2025-06-24 - URL: https://axcelead-us.com/topics/research-article-co-authored-on-ferroptosis-moa-analysis-published-in-communications-biology/ - Categories: Topics --- - Published: 2025-03-25 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/drug-discovery-chemistry-2025/ - Categories: Previous Conferences San Diego, CA --- - Published: 2025-02-20 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/bio-europe-spring-2025/ - Categories: Previous Conferences Milan, Italy --- - Published: 2025-02-12 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/global-life-science-partnering-%ef%bc%86investor-conference-2025/ - Categories: Previous Conferences San Diego, CA --- > Join Axcelead webinar to learn more about the latest technologies and insights in drug discovery and development! - Published: 2025-01-15 - Modified: 2025-03-11 - URL: https://axcelead-us.com/previous-seminars/accelerate-targeted-protein-degradation-drug-discovery-with-axceleads-integrated-platform-deglead/ - Categories: Previous Seminars Join this webinar to find out how we can help accelerate your Targeted Protein Degradation Drug Discovery! In this webinar, we will introduce our "DegLead Platform™," an integrated TPD platform, and showcase how our strengths—including specialized chemistry, a comprehensive compound library, diverse assay systems, and advanced ADME solutions—can drive success in your TPD projects. Additionally, we will share application case studies and valuable insights. --- - Published: 2024-12-26 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/20241226-e-newsrelease/ - Categories: News, News Releases --- - Published: 2024-12-13 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/slas2025-international-conference-exhibition/ - Categories: Previous Conferences San Diego, CA --- - Published: 2024-11-05 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/the-liver-meeting-tlm-2024/ - Categories: Previous Conferences San Diego, CA --- - Published: 2024-10-31 - Modified: 2025-06-24 - URL: https://axcelead-us.com/news/research-results-of-a-mouse-model-of-chronic-kidney-disease-axcc-mice-generated-in-axcelead-ddp-has-been-published-in-the-american-journal-of-pathology-as-a-co-authored-article/ - Categories: News, Topics --- > Join Axcelead webinar to learn more about the latest technologies and insights in drug discovery and development! - Published: 2024-10-31 - Modified: 2025-03-11 - URL: https://axcelead-us.com/previous-seminars/axceleads-integrated-hts-platform-powered-by-computational-chemistry-and-ai-ml/ - Categories: Previous Seminars Join this webinar to find out how we can help you identify promising novel leads! In this webinar, we will showcase our integrated HTS platform and share our successful track record. We will also highlight the latest advances powered by computational chemistry and AI/ML technologies. --- - Published: 2024-10-21 - Modified: 2025-06-24 - URL: https://axcelead-us.com/news/a-co-authored-paper-regarding-immunocompromised-type-1-diabetic-mini-pigs-was-published-in-the-cell-transplantation/ - Categories: News, Topics --- - Published: 2024-09-27 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/bio-europe-2024/ - Categories: Previous Conferences Stockholm, Sweden --- - Published: 2024-09-10 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/axcelead-drug-discovery-partners-enters-into-master-service-agreement-for-drug-discovery-projects-with-acadia-pharmaceuticals/ - Categories: News, News Releases --- - Published: 2024-09-05 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/axcelead-ddp-and-lilly-enter-into-research-and-collaboration-agreement/ - Categories: News, News Releases --- - Published: 2024-07-25 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/neuroscience-2024/ - Categories: Previous Conferences Chicago, IL --- - Published: 2024-05-29 - Modified: 2025-06-24 - URL: https://axcelead-us.com/news/axcelead-ddp-has-become-a-certified-provider-of-single-cell-gene-expression-solution-from-10x-genomics/ - Categories: News, Topics --- - Published: 2024-05-27 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/achieved-the-first-milestone-in-drug-discovery-support-to-otsuka-pharmaceutical/ - Categories: News, News Releases --- - Published: 2024-05-08 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/bio-international-convention-2024/ - Categories: Previous Conferences San Diego, CA --- - Published: 2024-04-01 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/change-of-representative-director/ - Categories: News, News Releases --- - Published: 2024-02-29 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/aacr-annual-meeting-2024/ - Categories: Previous Conferences San Diego, CA --- - Published: 2024-02-14 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/global-life-science-partnering-%ef%bc%86investor-conference/ - Categories: Previous Conferences San Diego, CA --- - Published: 2024-01-11 - Modified: 2024-01-31 - URL: https://axcelead-us.com/previous-seminars/accelerate-and-achieve-an-optimall-ind-for-your-project/ - Categories: Previous Seminars A webinar co-hosted by Axcelead Drug Discovery Partners (ADDP), SEKISUI MEDICAL, and KRCC. The webinar is for Korean scientists. After the speech, the breakout meeting rooms are available, where our experts will answer your further and detailed questions. 16:00 – 17:00 (KST) --- - Published: 2024-01-05 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/axcelead-ddps-english-version-of-official-website-renewed/ - Categories: News, News Releases --- - Published: 2023-12-25 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/axcelead-drug-discovery-partners-and-acadia-pharmaceuticals-launch-2nd-drug-discovery-project-in-neuroscience/ - Categories: News, News Releases --- - Published: 2023-12-15 - Modified: 2024-01-24 - URL: https://axcelead-us.com/previous-seminars/driving-innovative-drug-discovery-through-integrated-high-throughput-screening-platform-2/ - Categories: Previous Seminars High-throughput screening (HTS) is the key methodology to identify hit and lead compouds for drug discovery. The innovative technologies for drugging undruggable targets and IPS cells have been shed new light on small molecule drug discovery. --- - Published: 2023-12-15 - Modified: 2024-01-24 - URL: https://axcelead-us.com/previous-seminars/rapid-discovery-accelerate-drug-discovery-from-hit-id-to-clinic-2/ - Categories: Previous Seminars Mounting competitive pressure is forcing the biopharma industry to look at new ways to shorten the time scale for all aspects of drug discovery. --- - Published: 2023-12-15 - Modified: 2024-01-24 - URL: https://axcelead-us.com/previous-seminars/how-to-proceed-glp-toxicity-study-without-cynomolgus-monkeys-2/ - Categories: Previous Seminars High-throughput screening (HTS) is the key methodology to identify hit and lead compouds for drug discovery. The innovative technologies for drugging undruggable targets and IPS cells have been shed new light on small molecule drug discovery. --- - Published: 2023-12-13 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/in-vivo-science-and-axcelead-ddp-entered-into-cooperative-agreement-for-drug-discovery-services-using-disease-model-animals/ - Categories: News, News Releases --- - Published: 2023-12-09 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/name-of-conference-here/ - Categories: Previous Conferences Boston, MA --- - Published: 2023-12-01 - Modified: 2025-05-16 - URL: https://axcelead-us.com/previous-conferences/discovery-on-target-2023/ - Categories: Previous Conferences Sheraton Boston --- - Published: 2023-11-22 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/results-of-joint-research-with-the-university-of-tokyo-published-in-the-international-scientific-journal-nature-communications/ - Categories: News, News Releases --- - Published: 2023-11-10 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/fronteo-and-axcelead-ddp-sign-master-collaboration-agreement-for-ai-drug-discovery-support-partnership/ - Categories: News, News Releases --- - Published: 2023-10-03 - Modified: 2025-06-24 - URL: https://axcelead-us.com/news/bio-europe-meet-us-in-munich-germany/ - Categories: News, Topics --- - Published: 2023-09-12 - Modified: 2025-06-24 - URL: https://axcelead-us.com/news/discovery-on-target-2023-meet-us-in-boston/ - Categories: News, Topics --- - Published: 2023-08-23 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/axcelead-ddps-drug-discovery-support-business-honored-with-the-6th-japan-medical-research-and-development-grand-prize/ - Categories: News, News Releases --- - Published: 2023-07-06 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/discussions-begin-on-collaborative-genomic-drug-discovery-support-using-the-iqvia-genome-wide-study-platform/ - Categories: News, News Releases --- - Published: 2023-05-16 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/bio-international-convention-2023-meet-us-in-boston/ - Categories: News, News Releases --- - Published: 2023-05-12 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/luncheon-seminar-at-the-43rd-workshop-of-the-korean-society-of-nonclinical-study/ - Categories: News, News Releases --- - Published: 2023-04-20 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/interview-with-ikeura-president-and-ceo-of-axcelead-a-holding-company-was-published-in-pharma-japan-%e3%80%8eaxcelead-to-expand-overseas-biz-shoots-for-130-billion-yen-sales-and/ - Categories: News, News Releases --- - Published: 2023-04-13 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/change-of-president-ceo/ - Categories: News, News Releases --- - Published: 2023-03-10 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/orizuru-therapeutics-and-axcelead-ddp-collaborate-on-drug-discovery-support-services-regarding-ips-cells/ - Categories: News, News Releases --- - Published: 2023-02-20 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/teijin-and-axcelead-to-establish-drug-discovery-research-jv/ - Categories: News, News Releases --- - Published: 2023-02-03 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/axcelead-ddp-selected-as-project-partner-for-harvard-business-school-immersive-field-course/ - Categories: News, News Releases --- - Published: 2023-01-11 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/kaken-pharmaceutical-and-axcelead-ddp-begin-collaboration-to-create-innovative-new-drugs/ - Categories: News, News Releases --- - Published: 2022-12-27 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/thinkcyte-and-axcelead-ddp-collaborate-to-advance-novel-phenotypic-screening-methods/ - Categories: News, News Releases --- - Published: 2022-11-14 - Modified: 2025-06-24 - URL: https://axcelead-us.com/news/axcelead-drug-discovery-partners-inc-has-become-a-certified-provider-of-spatial-transcriptomics-technology-visium-from-10x-genomics/ - Categories: News, Topics --- - Published: 2022-11-02 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/axcelead-ddp-and-knowledge-palette-enter-into-a-collaborative-research-contract-on-gene-expression-analysis-concerning-drug-resistant-cancer/ - Categories: News, News Releases --- - Published: 2022-10-20 - Modified: 2025-06-24 - URL: https://axcelead-us.com/news/dr-hideo-fukui-will-chair-the-international-symposium-about-new-modalities-at-the-american-college-of-toxicology-2022-annual-meeting/ - Categories: News, Topics --- - Published: 2022-10-05 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/axcelead-drug-discovery-partners-and-acadia-pharmaceuticals-launch-drug-discovery-collaboration-in-neuroscience/ - Categories: News, News Releases --- - Published: 2022-09-01 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/epigeneron-and-axcelead-ddp-singed-a-master-collaboration-agreement-on-drug-discovery-research-for-novel-drug-targets/ - Categories: News, News Releases --- - Published: 2022-08-19 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/perseus-proteomics-and-axcelead-ddp-launch-a-collaboration-for-an-antibody-drug-discovery-support-service/ - Categories: News, News Releases --- - Published: 2022-07-20 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/arcalis-and-axcelead-ddp-announce-collaboration-to-provide-integrated-drug-discovery-support-service-for-mrna-therapeutics/ - Categories: News, News Releases --- - Published: 2022-03-31 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/axcelead-ddp-and-knowledge-palette-entered-into-a-collaborative-research-contract-for-establishment-of-a-new-evaluation-platform-using-axcelead-ddps-compound-libraries-and-large-scale-transcr/ - Categories: News, News Releases --- - Published: 2022-01-12 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/ip-generator-axcelead-and-axcelead-drug-discovery-partners-signed-a-comprehensive-business-alliance-agreement/ - Categories: News, News Releases --- - Published: 2021-12-15 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/hitachi-and-axcelead-ddp-launch-manufacturing-process-development-support-service-for-cell-therapy-and-gene-therapy/ - Categories: News, News Releases --- - Published: 2021-11-25 - Modified: 2025-05-21 - URL: https://axcelead-us.com/news/axcelead-drug-discovery-partners-was-rated-as-excellent-by-japan-agency-for-medical-research-and-development-amed-in-a-program-for-drug-discovery-seeds-development/ - Categories: News, News Releases --- ---